PREVENTIVE WOMAN'S CARD: DEVELOPMENT AND VALIDATION OF EDUCATIONAL TECHNOLOGY FOR CERVICAL CANCER SCREENING IN PRIMARY HEALTH CARE.
DOI:
https://doi.org/10.66104/j31ex392Keywords:
Cervical Cancer, Screening, Health Education, Educational Technology, Primary Health CareAbstract
Introduction: Cervical cancer remains one of the leading causes of cancer-related morbidity and mortality among women. The adoption of molecular testing for human papillomavirus DNA (HPV-DNA) as the primary screening method in Brazil underscores the need for educational strategies that promote understanding of and adherence to preventive measures. Objective: To develop and obtain evidence regarding the content validity, appearance, and semantic comprehension of the “Carteirinha da Mulher Prevenida” (Preventive Woman’s Card), an educational tool for health education and longitudinal monitoring of cervical cancer screening in Primary Health Care (PHC). Method: A quantitative methodological study conducted between April and June 2026. Components of Pasquali’s framework were adapted for the development of the educational technology and supplemented by specific literature. The educational technology, audited in accordance with the 2025 Brazilian Guidelines, was evaluated by ten health specialists, five design/communication experts, and ten women from the target audience. Content Validity Indices (CVI), Face Validity Indices (FVI), and Semantic Validity Indices (SVI) were calculated, with values ≥0.80 considered satisfactory. Results: The overall CVI was 0.997 (598/600), with final scores per item ranging from 0.95 to 1.00. The FVI per item ranged from 0.867 to 1.000. In the semantic validation, all ten participants provided concordant responses (3 or 4) on the 15 components evaluated, resulting in an SVI-I of 1.00. The suggestions led to adjustments in content, language, visual organization, frequency, and the fields for recording test results. Conclusion: The Carteirinha da Mulher Prevenida demonstrated satisfactory evidence of content validity, appearance, and semantic comprehension in the evaluated group. The technology incorporates up-to-date guidelines on oncogenic HPV DNA screening and longitudinal record-keeping, and can support educational initiatives in primary health care. Its effects on health literacy, self-care, and adherence to screening should be investigated in implementation and effectiveness studies.Downloads
References
Alexandre, N. M. C., and M. Z. O. Coluci. “Validade de Conteúdo nos Processos de Construção e Adaptação de Instrumentos de Medida.” Ciência & Saúde Coletiva, vol. 16, no. 7, 2011, pp. 3061–3068. https://doi.org/10.1590/1413-81232015203.04332013 DOI: https://doi.org/10.1590/S1413-81232011000800006
BRASIL. Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Controle do Câncer do Colo do Útero. Ministério da Saúde, 2022.
Brasil. Instituto Nacional de Câncer José Alencar Gomes da Silva. Diretrizes Brasileiras para o Rastreamento do Câncer do Colo do Útero. 2. ed., INCA, 2025.
BRASIL. Ministério da Saúde. Protocolo de Atenção Integral à Saúde da Mulher. Ministério da Saúde, 2020.
BRASIL,2024b. Ministério da Saúde. Comissão Nacional de Incorporação de Tecnologias no SUS – Conitec. Relatório de Recomendação: Diretrizes Brasileiras para o Rastreamento do Câncer do Colo do Útero. Parte I – Rastreamento Organizado Utilizando Testes Moleculares para Detecção de DNA-HPV Oncogênico. Ministério da Saúde, 2024.
BRASIL. Ministério da Saúde. Relatório CP Testagem Molecular Detecção HPV 65/2023. Ministério da Saúde, 2023.
BRASIL. Ministério da Saúde. Diretrizes Brasileiras para o Rastreamento do Câncer do Colo do Útero. 2. ed., Ministério da Saúde, 2024.
BRASIL. Ministério da Saúde, Secretaria de Atenção Especializada à Saúde, e Instituto Nacional de Câncer. Nota Técnica nº 1/2024-INCA. Ministério da Saúde, 2024.
BRASIL, 2024a. Ministério da Saúde. Secretaria de Ciência, Tecnologia e Inovação e do Complexo Econômico-Industrial da Saúde. Portaria SECTICS/MS nº 3, de 7 de março de 2024. Torna pública a decisão de incorporar, no âmbito do SUS, testes moleculares para detecção de HPV oncogênico para o rastreamento do câncer do colo do útero. Brasília, DF: Ministério da Saúde, 2024. Disponível em: www.gov.br. Acesso em: 24 out. 2026.
BRASIL. Ministério da Saúde. Secretaria de Atenção Especializada à Saúde; Secretaria de Ciência, Tecnologia, Inovação e do Complexo Econômico-Industrial da Saúde. Portaria Conjunta SAES/SECTICS nº 13, de 29 de julho de 2025. Aprova as Diretrizes Brasileiras para o Rastreamento do Câncer de Colo do Útero: Parte I – rastreamento organizado utilizando testes moleculares para detecção de DNA-HPV oncogênico. Brasília, DF: Ministério da Saúde, 2025. Disponível em: www.gov.br. Acesso em: 24 out. 2026.
CRUZ, Luana Fernandes; MACIEL, Jessyca Moreira; SALES, Janayle Kéllen Duarte de; RODRIGUES, Lívia Monteiro; SANTOS, Sheron Maria Silva; CRUZ, Rachel de Sá Barreto Luna Callou; OLIVEIRA, Dayanne Rakelly de; CAVALCANTE, Edilma Gomes Rocha. Educação em saúde para adesão ao Papanicolaou: uma revisão de literatura. Revista Brasileira em Promoção da Saúde, [S. l.], v. 36, 2023. DOI: 10.5020/18061230.2023.13164. Disponível em: https://ojs.unifor.br/RBPS/article/view/13164. DOI: https://doi.org/10.5020/18061230.2023.13164
CUNHA, I.I.B.R. et al. Câncer de colo uterino: fisiopatologia, manifestações clínicas e principais fatores de risco associados à patogênese. Research, Society and Development, v. 11, n. 11, p. e491111133992, 2022. Disponível em: Doi: 10.33448/rsd-v11i11.33992. DOI: https://doi.org/10.33448/rsd-v11i11.33992
DAVILLA, M. S. D., et al. “Objeto virtual de aprendizagem sobre rastreamento do câncer do colo do útero.” Acta Paulista de Enfermagem, vol. 34, 2021, eAPE00063. DOI: 10.37689/acta-ape/2021AO00063. DOI: https://doi.org/10.37689/acta-ape/2021AO00063
FRAGA, B. L. G. C., et al. “Desmistificando a coleta citopatológica: uma forma de prevenir o câncer de colo do útero.” Revista Nursing, vol. 26, no. 303, 2023, pp. 9841–9844. DOI: 10.36489/nursing.2023v26i303p9841-9844. DOI: https://doi.org/10.36489/nursing.2023v26i303p9841-9844
GOMES, R. S., et al. “Linha de cuidado do câncer do colo do útero no Amazonas: uma análise da prevenção ao tratamento de lesões precursoras.” Revista Brasileira de Cancerologia, vol. 68, no. 2, 2022, e1282. DOI: 10.32635/2176-9745.RBC.2022v68n2.1282.
INCA. Instituto Nacional de Câncer José Alencar Gomes da Silva. Câncer do Colo do Útero. INCA, 2023.
INCA. Instituto Nacional de Câncer José Alencar Gomes da Silva. Diretrizes Brasileiras para o Rastreamento do Câncer do Colo do Útero. 2. ed., INCA, 2016.
INCA. Instituto Nacional de Câncer José Alencar Gomes da Silva. Estimativa 2023: Incidência de Câncer no Brasil. INCA, 2022.
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER (IARC). IARC Handbooks of Cancer Prevention: Cervical Cancer Screening. IARC, 2024.
MESQUITA, L. A., et al. “Development and validation of educational material for the prevention and management of disabilities in women treated for cervical cancer.” Fisioterapia e Pesquisa, vol. 33, 2026, e24018326. DOI: https://doi.org/10.1590/1809-2950/e24018326en
NUTBEAM, D., and J. E. LLOYD. “Understanding and responding to health literacy as a social determinant of health.” Annual Review of Public Health, vol. 42, 2021, pp. 159–173. DOI: https://doi.org/10.1146/annurev-publhealth-090419-102529
PASQUALI, LUIZ. Instrumentação Psicológica: Fundamentos e Práticas. Artmed, 2010.
Peuker, A. C., et al. “Construção de um Material Educativo para a Prevenção do Câncer de Colo do Útero.” Estudos Interdisciplinares em Psicologia, vol. 8, no. 2, 2017, pp. 146–160, https://doi.org/10.5433/2236-6407.2017v8n2p146. DOI: https://doi.org/10.5433/2236-6407.2017v8n2p146
Silva, S. O., et al. “Semantic Validation of Educational Technology with Caregivers of Children and Adolescents Undergoing Chemotherapy.” Revista Brasileira de Enfermagem, vol. 75, no. 5, 2022, e20220294, https://doi.org/10.1590/0034-7167-2022-0294 DOI: https://doi.org/10.1590/0034-7167-2022-0294pt
XIMENES, M. L., et al. “Estudo de validação de tecnologia educativa sobre braquiterapia ginecológica de alta taxa de dose (HDR).” Revista Brasileira de Enfermagem, vol. 76, supl. 4, 2023, e20220232. DOI: https://doi.org/10.1590/0034-7167-2022-0232
Published
Issue
Section
License
Copyright (c) 2026 Cybele Peres Silva Canhin, Daiane Oliveira Santana, Jakeline Pulquerio Varjão Campos, Mariana Alves da Silva, Natália Malavasi Vallejo, Tiago Barcelos Valiatti

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in this journal agree to the following terms:
Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution License, which permits the sharing of the work with proper acknowledgment of authorship and initial publication in this journal;
Authors are authorized to enter into separate, additional agreements for the non-exclusive distribution of the version of the work published in this journal (e.g., posting in an institutional repository or publishing it as a book chapter), provided that authorship and initial publication in this journal are properly acknowledged, and that the work is adapted to the template of the respective repository;
Authors are permitted and encouraged to post and distribute their work online (e.g., in institutional repositories or on their personal websites) at any point before or during the editorial process, as this may lead to productive exchanges and increase the impact and citation of the published work (see The Effect of Open Access);
Authors are responsible for correctly providing their personal information, including name, keywords, abstracts, and other relevant data, thereby defining how they wish to be cited. The journal’s editorial board is not responsible for any errors or inconsistencies in these records.
PRIVACY POLICY
The names and email addresses provided to this journal will be used exclusively for the purposes of this publication and will not be made available for any other purpose or to third parties.
Note: All content of the work is the sole responsibility of the author and the advisor.
